InflaRx (IFRX) Payables (2016 - 2026)
InflaRx's Payables was $6.17 million in Q2 2026, down 100.0% from $11.02 trillion a year earlier but up 8.7% from the prior quarter.
Powered by 
Analysis
InflaRx (IFRX) Payables (2016 - 2026) Analysis & Trends
At the end of FY2025, Payables at InflaRx came in at $6.1 million, down 100.0% from FY2024.
- Payables shows a five-year compound annual growth rate of -9.1% (FY2020 to FY2025).
- In earlier years, Payables was $12.18 trillion in FY2024 (-5.5%), $12.88 trillion in FY2023, $5.09 million in FY2022 (-100.0%) and $9.81 trillion in FY2021.
- Quarterly Payables has moved between $4.95 million (Q1 2023) and $12.88 trillion (Q4 2023) over five years.
- Compared with a year earlier, Payables has declined for four straight quarters, with an average decline of 22.0% over the last seven quarters.
- The best year-over-year quarter for Payables over five years was Q3 2024 (growth of 97.1%); the worst was Q4 2025 (a decline of 100.0%).
- Per Business Quant data, IFRX's Payables in the three quarters before Q2 2026 was $5.67 million (Q1 2026), $6.29 million (Q4 2025) and $10.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.46 Bn | 1,101.04 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 614.45 Bn | 532.98 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.76 Bn | 476.87 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 367.67 Bn | 322.05 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.09 Bn | 262.08 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.81 Bn | 235.50 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.49 Bn | 191.89 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.25 Bn | 165.45 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.18 Bn | 116.83 Bn | 10.94 Bn | 7.03 Bn |
| 10 | InflaRx | 105.31 Mn | -228.31 Mn | 2.74 Mn | 6.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.06 Mn |
| Mar 31, 2026 | 5.55 Mn |
| Dec 31, 2025 | 6.34 Mn |
| Sep 30, 2025 | 10.83 Mn |
| Jun 30, 2025 | 11.42 Mn |
| Mar 31, 2025 | 9.06 Mn |
| Dec 31, 2024 | 11.86 Mn |
| Sep 30, 2024 | 13.09 Mn |
| Jun 30, 2024 | 9.15 Mn |
| Mar 31, 2024 | 8.21 Mn |
| Dec 31, 2023 | 13.25 Mn |
| Sep 30, 2023 | 6.34 Mn |
| Jun 30, 2023 | 5.65 Mn |
| Mar 31, 2023 | 5.03 Mn |
| Dec 31, 2022 | 5.32 Mn |
| Sep 30, 2022 | 7.31 Mn |
| Jun 30, 2022 | 8.27 Mn |
| Mar 31, 2022 | 10.61 Mn |
| Dec 31, 2021 | 9.71 Mn |
| Sep 30, 2021 | 13.36 Mn |
API Access
InflaRx Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();